Biotech Values

[semi_infinite]

It will be interesting to see what ISRG comes up with for lung biopsy as they have rights to develop the technology outside of blood vessels and they have been working on it with Fosun. Moll's best success so far has been Mako. ISRG wasn't a success until Moll left and switched focus to prostate from heart. Hansen failed because their cabled technology was too stiff and traumatic for heart procedures (very high rate of mortality compared to manual) and they abandoned that business. Seems Olympus would be looking at robotics too. Medrobotics via CMU looks interesting as well but not sure if that can be scaled down in diameter. Moll has a hand in HAIR as well. Dentistry can use robotics as there is a lot of wear and tear on DDS.